Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Monday, March 10, 2014 - 8:23am
tags:
InterMune, Aegerion, Emergent BioSolutions
Sequenom 2013 Operating Results Review
Seeking Alpha
Monday, March 10, 2014 - 8:22am
tags:
earnings, Sequenom
Reckitt Benckiser to buy K-Y from Johnson & Johnson
Yahoo/Reuters
Monday, March 10, 2014 - 8:21am
tags:
Reckitt Benckiser, JNJ, K-Y
Prices of new hepatitis C drugs are tough to swallow for insurers
LA Times, CA
Monday, March 10, 2014 - 8:19am
tags:
insurance, hepatitis C, Sovaldi, Gilead Sciences, Olysio, JNJ, Janssen
AstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient
Wall St Cheat Sheet
Monday, March 10, 2014 - 8:15am
tags:
Nexium, Ranbaxy, recalls, AstraZeneca
GlaxoSmithKline - Not Too Easy To Put Down
Seeking Alpha
Monday, March 10, 2014 - 8:14am
tags:
GSK
Drugs for rare diseases looming health hazard
Toronto Star, Canada
Sunday, March 9, 2014 - 1:44pm
tags:
orphan drugs, rare disease
2 senators investigate Zohydro OK
American Live Wire
Sunday, March 9, 2014 - 1:41pm
tags:
Zohydro, Zogenix, pain management, opiods
AbbVie's Humira Still a Growth Engine
Motley Fool
Sunday, March 9, 2014 - 1:35pm
tags:
AbbVie, Humira, rheumatoid arthritis, psoriasis
Investing In The Future: Illumina
Seeking Alpha
Sunday, March 9, 2014 - 1:32pm
tags:
Illumina
Has Celgene Corporation Run Out of Steam in 2014?
Motley Fool
Sunday, March 9, 2014 - 1:32pm
tags:
Celgene
This Week in Biotech: Put It in Print
Motley Fool
Sunday, March 9, 2014 - 1:31pm
tags:
Endo, Aveed, Rigel Pharmaceuticals, R118, Sangamo BioSciences, SB-728-T, NewLink Genetics, Xoma, gevokizumab
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Pharmabiz
Saturday, March 8, 2014 - 10:49am
tags:
SVR12, Boehringer Ingelheim, HCV, HIV, hepatitis, hepatitis C
Ranbaxy Recalls Generic Lipitor in U.S. After Dose Mix-Up Found
Bloomberg
Saturday, March 8, 2014 - 10:41am
tags:
Ranbaxy, generics, Lipitor, recalls
Better Buy: Biogen Or Amgen?
Motley Fool
Saturday, March 8, 2014 - 10:39am
tags:
Amgen, Biogen
Can Bristol-Myers Squibb Keep Its Bull Run Going in 2014?
Motley Fool
Saturday, March 8, 2014 - 10:37am
tags:
Bristol-Myers Squibb
InterMune Wins Amid More Takeover Rumors
Motley Fool
Saturday, March 8, 2014 - 10:35am
tags:
InterMune
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Galena Biopharma, Inc.
Yahoo/Globe Newswire
Saturday, March 8, 2014 - 10:34am
tags:
lawsuits
The Spark of Innovation at Vertex Pharmaceuticals Incorporated
Motley Fool
Saturday, March 8, 2014 - 10:32am
tags:
Vertex Pharmaceuticals
FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes
Saturday, March 8, 2014 - 10:31am
tags:
PCSK9 inhibitors, Regeneron, Sanofi, hypercholesterolemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.